Li M, Zheng R, Liu Z, Zhang P, Zhu T, Xin X
Front Immunol. 2025; 15():1502936.
PMID: 39776916
PMC: 11703830.
DOI: 10.3389/fimmu.2024.1502936.
Shin H, Kim H, Kwon S, Lee H, Lee J, Kim Y
Mol Cells. 2025; 48(2):100175.
PMID: 39743142
PMC: 11873615.
DOI: 10.1016/j.mocell.2024.100175.
Tachita T, Ri M, Aoki S, Asano A, Kanamori T, Totani H
Cancer Med. 2024; 13(14):e70019.
PMID: 39031503
PMC: 11259000.
DOI: 10.1002/cam4.70019.
Lekan A, Weiner L
Cancers (Basel). 2024; 16(3).
PMID: 38339310
PMC: 10854906.
DOI: 10.3390/cancers16030559.
Dower W, Park A, Bakker A, Cwirla S, Pongtornpipat P, Williams B
PLoS One. 2023; 18(10):e0286834.
PMID: 37874823
PMC: 10597491.
DOI: 10.1371/journal.pone.0286834.
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development.
Tang L, Pan S, Wei X, Xu X, Wei Q
Mol Ther. 2023; 31(11):3146-3162.
PMID: 37803832
PMC: 10638038.
DOI: 10.1016/j.ymthe.2023.09.021.
Immune subset-committed proliferating cells populate the human foetal intestine throughout the second trimester of gestation.
Guo N, Li N, Jia L, Jiang Q, Schreurs M, van Unen V
Nat Commun. 2023; 14(1):1318.
PMID: 36899020
PMC: 10006174.
DOI: 10.1038/s41467-023-37052-4.
Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+ T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control.
Vimali J, Yong Y, Murugesan A, Vishnupriya K, Ashwin R, Daniel E
Front Med (Lausanne). 2022; 9:1019230.
PMID: 36405584
PMC: 9668853.
DOI: 10.3389/fmed.2022.1019230.
Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunity.
Xiao Q, Yu F, Yan L, Zhao H, Zhang F
Front Immunol. 2022; 13:1026070.
PMID: 36325329
PMC: 9618587.
DOI: 10.3389/fimmu.2022.1026070.
Lymphopenia and Mechanisms of T-Cell Regeneration.
Saidakova E
Cell tissue biol. 2022; 16(4):302-311.
PMID: 35967247
PMC: 9358362.
DOI: 10.1134/S1990519X2204006X.
A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy.
Lagou M, Anastasiadou D, Karagiannis G
Front Immunol. 2022; 13:933547.
PMID: 35844592
PMC: 9283860.
DOI: 10.3389/fimmu.2022.933547.
Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?.
Safarzadeh Kozani P, Safarzadeh Kozani P, Ahmadi Najafabadi M, Yousefi F, Mirarefin S, Rahbarizadeh F
Front Immunol. 2022; 13:795164.
PMID: 35634281
PMC: 9130586.
DOI: 10.3389/fimmu.2022.795164.
Folate Receptor-Alpha Targeted 7x19 CAR-T Suppressed Triple-Negative Breast Cancer Xenograft Model in Mice.
Ye X, Deng X, Wen J, Li Y, Zhang M, Cai Z
J Oncol. 2022; 2022:2112898.
PMID: 35295709
PMC: 8920629.
DOI: 10.1155/2022/2112898.
Multipurposing CARs: Same engine, different vehicles.
Hossian A, Hackett C, Brentjens R, Rafiq S
Mol Ther. 2022; 30(4):1381-1395.
PMID: 35151842
PMC: 9077369.
DOI: 10.1016/j.ymthe.2022.02.012.
Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials.
Smirnov S, Petukhov A, Levchuk K, Kulemzin S, Staliarova A, Lepik K
Front Immunol. 2022; 12:780145.
PMID: 34975869
PMC: 8714645.
DOI: 10.3389/fimmu.2021.780145.
Roles of Clara cell 10-kD protein and type 2 innate lymphoid cells in allergic rhinitis.
Long X, Wang N, Zhang X
Cell Cycle. 2021; 20(18):1923-1934.
PMID: 34437822
PMC: 8525930.
DOI: 10.1080/15384101.2021.1966961.
The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma.
Duan D, Wang K, Wei C, Feng D, Liu Y, He Q
Front Immunol. 2021; 12:609421.
PMID: 33767695
PMC: 7985831.
DOI: 10.3389/fimmu.2021.609421.
Master regulator genes and their impact on major diseases.
Cai W, Zhou W, Han Z, Lei J, Zhuang J, Zhu P
PeerJ. 2020; 8:e9952.
PMID: 33083114
PMC: 7546222.
DOI: 10.7717/peerj.9952.
The Cytokine Receptor IL-7Rα Impairs IL-2 Receptor Signaling and Constrains the In Vitro Differentiation of Foxp3 Treg Cells.
Waickman A, Keller H, Kim T, Luckey M, Tai X, Hong C
iScience. 2020; 23(8):101421.
PMID: 32791329
PMC: 7424196.
DOI: 10.1016/j.isci.2020.101421.
The Emerging Landscape of Immune Cell Therapies.
Weber E, Maus M, Mackall C
Cell. 2020; 181(1):46-62.
PMID: 32243795
PMC: 8900215.
DOI: 10.1016/j.cell.2020.03.001.